Within the past 90 days HealthEquity has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
|10 Day Gain
HealthEquity rank is 354
The StockSelector Value for HealthEquity is $261.06. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, HealthEquity is ranked 362.
|90 Day Gain
HealthEquity rank is 604
The average analysts' target price is $77.00 for HealthEquity using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, HealthEquity is ranked 808.
HealthEquity has a low Put/Call ratio of 0.62 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, HealthEquity is ranked 1566.
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, HealthEquity is ranked 72.
|Negative Stoch Cross
HealthEquity rank is 108
According to EarningsWhispers.com, HealthEquity missed the Earnings Whisper ® number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper ® number underperform the market in the short-term.
HealthEquity has a high Put/Call ratio of 0.86 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, HealthEquity is ranked 1587.